Medusa Pharmaceuticals Overview

  • Year Founded
  • 2021

Year Founded

  • Status
  • Private

  • Employees
  • 2

Employees

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 4

Medusa Pharmaceuticals General Information

Description

Developer of antimicrobial technologies designed to restore the effectiveness of existing antibiotics against resistant bacterial infections. The company's platform revitalizes antibiotic potency through a novel mechanism that counteracts bacterial defense adaptations, enabling healthcare providers and researchers to combat antimicrobial resistance, reduce treatment failures, and save lives threatened by untreatable infections worldwide.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Corporate Office
  • Kingsbury House 468
  • Church Lane
  • London NW9 8UA
  • England, United Kingdom
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Drug Discovery
Vertical(s)
Corporate Office
  • Kingsbury House 468
  • Church Lane
  • London NW9 8UA
  • England, United Kingdom

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Medusa Pharmaceuticals Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Accelerator/Incubator 19-Sep-2024 Completed Generating Revenue
3. Grant 01-Nov-2022 Completed Generating Revenue
2. Accelerator/Incubator 28-Sep-2021 $13.8K $13.8K Completed Generating Revenue
1. University Spin-Out 11-Mar-2021 Completed Generating Revenue
To view Medusa Pharmaceuticals’s complete valuation and funding history, request access »

Medusa Pharmaceuticals Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Medusa Pharmaceuticals Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
Science Entrepreneur Club Accelerator/Incubator
Innovate UK Government
Accelerate@Babraham Accelerator/Incubator
Imperial College London University
To view Medusa Pharmaceuticals’s complete investors history, request access »

Medusa Pharmaceuticals FAQs

  • When was Medusa Pharmaceuticals founded?

    Medusa Pharmaceuticals was founded in 2021.

  • Where is Medusa Pharmaceuticals headquartered?

    Medusa Pharmaceuticals is headquartered in London, United Kingdom.

  • What is the size of Medusa Pharmaceuticals?

    Medusa Pharmaceuticals has 2 total employees.

  • What industry is Medusa Pharmaceuticals in?

    Medusa Pharmaceuticals’s primary industry is Biotechnology.

  • Is Medusa Pharmaceuticals a private or public company?

    Medusa Pharmaceuticals is a Private company.

  • What is Medusa Pharmaceuticals’s current revenue?

    The current revenue for Medusa Pharmaceuticals is .

  • How much funding has Medusa Pharmaceuticals raised over time?

    Medusa Pharmaceuticals has raised $13.8K.

  • Who are Medusa Pharmaceuticals’s investors?

    Science Entrepreneur Club, Innovate UK, Accelerate@Babraham, and Imperial College London have invested in Medusa Pharmaceuticals.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process